Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Mar. 20, 2026 |
Jun. 30, 2025 |
|
| Cover [Abstract] | |||
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | Immix Biopharma, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend its Annual Report on Form 10-K for the year ended December 31, 2025, previously filed with the Securities and Exchange Commission (the “SEC”) on March 25, 2026 (the “Original Filing”), for the sole purpose of reflecting the correct date of the Report of Independent Registered Public Accounting Firm (the “Auditor Report”) (correct: March 25, 2026). No other changes have been made to the financial reports or 10-K content compared to the 10-K filed on March 25, 2026.In addition, pursuant to the rules of the SEC, the exhibit list included herewith reflects currently-dated auditor consent and certifications from the Company’s Chief Executive Officer and Chief Financial Officer, which are filed as exhibits to this Amendment No. 1.Except for the foregoing amended information, this Amendment No. 1 does not amend or update any other information contained in the Original Filing, or reflect any events that have occurred after the filing of the Original Filing. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2025 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2025 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 001-41159 | ||
| Entity Registrant Name | IMMIX BIOPHARMA, INC. | ||
| Entity Central Index Key | 0001873835 | ||
| Entity Tax Identification Number | 45-4869378 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 11400 West Olympic Blvd. | ||
| Entity Address, Address Line Two | Suite 200 | ||
| Entity Address, City or Town | Los Angeles | ||
| Entity Address, State or Province | CA | ||
| Entity Address, Postal Zip Code | 90064 | ||
| City Area Code | (310) | ||
| Local Phone Number | 651-8041 | ||
| Title of 12(b) Security | Common stock, $0.0001 par value | ||
| Trading Symbol | IMMX | ||
| Security Exchange Name | NASDAQ | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Elected Not To Use the Extended Transition Period | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 35,708,995 | ||
| Entity Common Stock, Shares Outstanding | 52,964,549 | ||
| Documents Incorporated by Reference [Text Block] | Portions of the registrant’s definitive proxy statement (the “2026 Proxy Statement”) relating to its 2026 annual meeting of stockholders (the “2026 Annual Meeting of Stockholders”) are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. The 2026 Proxy Statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates. | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Auditor Firm ID | 173 | ||
| Auditor Name | Crowe LLP | ||
| Auditor Location | Los Angeles, California |